Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Nanomedicine ; 18: 8169-8185, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-38169997

RESUMO

Introduction: The development of new materials and tools for radiology is key to the implementation of this diagnostic technique in clinics. In this work, we evaluated the differential accumulation of peptide-functionalized GNRs in a transgenic animal model (APPswe/PSENd1E9) of Alzheimer's disease (AD) by computed tomography (CT) and measured the pharmacokinetic parameters and bioaccumulation of the nanosystem. Methods: The GNRs were functionalized with two peptides, Ang2 and D1, which conferred on them the properties of crossing the blood-brain barrier and binding to amyloid aggregates, respectively, thus making them a diagnostic tool with great potential for AD. The nanosystem was administered intravenously in APPswe/PSEN1dE9 model mice of 4-, 8- and 18-months of age, and the accumulation of gold nanoparticles was observed by computed tomography (CT). The gold accumulation and biodistribution were determined by atomic absorption. Results: Our findings indicated that 18-month-old animals treated with our nanosystem (GNR-D1/Ang2) displayed noticeable differences in CT signals compared to those treated with a control nanosystem (GNR-Ang2). However, no such distinctions were observed in younger animals. This suggests that our nanosystem holds the potential to effectively detect AD pathology. Discussion: These results support the future development of gold nanoparticle-based technology as a more effective and accessible alternative for the diagnosis of AD and represent a significant advance in the development of gold nanoparticle applications in disease diagnosis.


Assuntos
Doença de Alzheimer , Nanopartículas Metálicas , Nanotubos , Camundongos , Animais , Ouro/química , Bioacumulação , Distribuição Tecidual , Nanopartículas Metálicas/química , Peptídeos/química , Doença de Alzheimer/diagnóstico por imagem , Doença de Alzheimer/metabolismo , Amiloide/metabolismo , Tomografia Computadorizada por Raios X , Nanotubos/química , Tomografia , Peptídeos beta-Amiloides/metabolismo , Camundongos Transgênicos , Modelos Animais de Doenças , Encéfalo/metabolismo
2.
Colloids Surf B Biointerfaces ; 166: 323-329, 2018 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-29625410

RESUMO

We studied the photothermal release of carboxyfluorescein (CF) linked to the gold surface of gold nanorods (GNRs) by two Diels-Alder adducts of different lengths (n = 4 and n = 9). The functionalized GNRs were irradiated with infrared light to produce photothermal release of CF by a retro-Diels-Alder reaction. The adducts were chemisorbed on the GNRs and the functionalized nanoparticles were characterized by UV-vis, DLS, zeta potential and Raman and surface-enhanced Raman spectroscopy (SERS). On the basis of the degree of nanoparticle functionalization and the SERS results, we inferred the orientation of CF on the surface of the gold nanoparticle. Moreover, we determined the photothermal release profiles of CF from the gold surface by laser irradiation. The release was faster for the longer linker (n = 9). SERS revealed that, for the shorter linker (n = 4), molecules are oriented perpendicularly with respect to the gold surface, thereby maintaining the CF far from the surface. In contrast, the longer linker was observed to be tilted, thus maintaining CF close to the gold surface and therefore potentially favoring the photothermal transfer of energy. These results are relevant for the future development of the spatial and temporal controlled release of drugs by means of gold nanoparticles.


Assuntos
Ouro/química , Nanopartículas Metálicas/química , Nanotubos/química , Análise Espectral Raman
3.
J Colloid Interface Sci ; 453: 260-269, 2015 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-25989057

RESUMO

Anisotropic and branched gold nanoparticles have great potential in optical, chemical and biomedical applications. However their syntheses involve multi-step protocols and the use of cytotoxic agents. Here, we report a novel one-step method for the preparation of gold nanostructures using only Hantzsch 1,4-dihydropyridines as mild reducing agents. The substituent pattern of the dihydropyridine nucleus was closely related to the ease of formation, morphology and stability of the nanoparticles. We observed nanostructures such as spheres, rods, triangles, pentagons, hexagons, flowers, stars and amorphous. We focused mainly on the synthesis and characterization of well-defined gold nanostars, which were produced quickly at room temperature (25°C) in high yield and homogeneity. These nanostars presented an average size of 68 nm with mostly four or six tips. Based on our findings, we propose that the growth of the nanostars occurs in the (111) lattice plane due to a preferential deposition of the gold atoms in the early stages of particle formation. Furthermore, the nanostars were easily modified with peptides remaining stable for more than six months in their colloidal state and showing a better stability than unmodified nanostars in different conditions. We report a new approach using dihydropyridines for the straightforward synthesis of gold nanostructures with controlled shape, feasible for use in future applications.


Assuntos
Di-Hidropiridinas/química , Ouro/química , Nanoestruturas/química , Nanoestruturas/ultraestrutura , Substâncias Redutoras/química , Nanotecnologia/métodos
4.
Bioconjug Chem ; 23(3): 399-408, 2012 Mar 21.
Artigo em Inglês | MEDLINE | ID: mdl-22284226

RESUMO

Gold nanoparticles (AuNPs) have been extensively used in biological applications because of their biocompatibility, size, and ease of characterization, as well as an extensive knowledge of their surface chemistry. These features make AuNPs readily exploitable for biomedical applications, including drug delivery and novel diagnostic and therapeutic approaches. In a previous work, we studied ex vivo distribution of the conjugate C(AuNP)-LPFFD for its potential uses in the treatment of Alzheimer's disease. In this study, we covalently labeled the conjugate with [(18)F]-fluorobenzoate to study the in vivo distribution of the AuNP by positron emission tomography (PET). After intravenous administration in rat, the highest concentration of the radiolabeled conjugate was found in the bladder and urine with a lower proportion in the intestine, demonstrating progressive accumulation compatible with biliary excretion of the conjugate. The conjugate also accumulated in the liver and spleen. PET imaging allowed us to study the in vivo biodistribution of the AuNPs in a noninvasive and sensitive way using a reduced number of animals. Our results show that AuNPs can be covalently and radioactively labeled for PET biodistribution studies.


Assuntos
Radioisótopos de Flúor/farmacocinética , Ouro/química , Nanopartículas Metálicas , Peptídeos/farmacocinética , Animais , Cromatografia Líquida de Alta Pressão , Avaliação Pré-Clínica de Medicamentos , Masculino , Microscopia Eletrônica de Transmissão , Peptídeos/química , Tomografia por Emissão de Pósitrons , Ratos , Ratos Sprague-Dawley , Espectrofotometria Ultravioleta , Ressonância de Plasmônio de Superfície , Distribuição Tecidual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA